Hims & Hers Health (HIMS) Operating Leases (2021 - 2026)
Hims & Hers Health (HIMS) reported Operating Leases of $157.9 million for Q1 2026, up 149.17% on a YoY basis from $63.4 million in Q1 2025, and up 10.31% sequentially from $143.2 million in Q4 2025.
Hims & Hers Health (HIMS) Operating Leases (2021 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 6 years of Operating Leases data on file, last reported at $157.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases rose 149.17% year-over-year to $157.9 million; the trailing twelve-month figure through Mar 2026 stood at $157.9 million (up 149.17% YoY), and the FY2025 full-year result was $143.2 million, up 1414.03% from the prior year.
- Operating Leases advanced to $157.9 million in Q1 2026, from $143.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $157.9 million in Q1 2026 to a low of $2.8 million in Q3 2023.
- A 5-year average of $39.2 million and a median of $9.5 million in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases tumbled 50.88% in 2023 and soared 1414.03% in 2025, its largest moves.
- Tracing HIMS's Operating Leases over 5 years: stood at $3.6 million in 2022, then soared by 137.52% to $8.7 million in 2023, then increased by 9.1% to $9.5 million in 2024, then soared by 1414.03% to $143.2 million in 2025, then gained by 10.31% to $157.9 million in 2026.
- Business Quant data shows HIMS's Operating Leases at $157.9 million in Q1 2026, $143.2 million in Q4 2025, and $147.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157.93 Mn |
| Dec 31, 2025 | 143.17 Mn |
| Sep 30, 2025 | 147.00 Mn |
| Jun 30, 2025 | 74.92 Mn |
| Mar 31, 2025 | 63.38 Mn |
| Dec 31, 2024 | 9.46 Mn |
| Sep 30, 2024 | 11.36 Mn |
| Jun 30, 2024 | 11.48 Mn |
| Mar 31, 2024 | 11.82 Mn |
| Dec 31, 2023 | 8.67 Mn |
| Sep 30, 2023 | 2.80 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 5.70 Mn |
| Jun 30, 2022 | 3.40 Mn |
| Mar 31, 2022 | 3.80 Mn |
| Dec 31, 2021 | 4.12 Mn |